It showed differences in gastrointestinal effects between milk containing A1 and A2 beta-casein protein.
The results supported findings of previous animal studies that there were differences in the way A1 and A2 milk proteins affects the body.
Associate Professor Sebely Pal, who led the research, said: “This pilot study shows that A2 milk, because it doesn’t have any A1 beta-casein, has different gastrointestinal effects.
“The milk that contained A1 beta-casein led to statistically significant differences in stool consistency, with the A1 being looser. This effect was particularly strong for women.”
Babidge said: “The reported outcomes are significant in providing further insight into the digestive benefits that thousands of a2 Milk consumers experience every day.
“It further underpins our belief that more consumers can enjoy the benefits of natural dairy milk without having to resort to modified milk and non-dairy alternatives.”
The a2 Milk Company encouraged the academic community to step up the research into the differences between the A2 and A1 proteins in dairy products and their potential impact on human health.
